1. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. Issue 6 (26th August 2021) Authors: Sulkowski, Mark S.; Moon, Juhi S.; Sherman, Kenneth E.; Morelli, Giuseppe; Darling, Jama M.; Muir, Andrew J.; Khalili, Mandana; Fishbein, Dawn A.; Hinestrosa, Federico; Shiffman, Mitchell L.; Di Bisceglie, Adrian; Rajender Reddy, K.; Pearlman, Brian; Lok, Anna S.; Fried, Michael W.; Stewart, Paul... Journal: Hepatology Issue: Volume 74:Issue 6(2021) Page Start: 2952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Concordance between Patients and Clinicians for Reporting Symptoms Associated with Treatment for Chronic Hepatitis C during a Pragmatic Clinical Trial. (4th July 2022) Authors: Reeve, Bryce B.; Michael, Larry; Peter, Joy A.; Stewart, Paul W.; Lok, Anna S.-F.; Dong, Meichen; Bergquist, Ken; Nelson, David R.; Evon, Donna M. Other Names: Maung Soe Thiha Academic Editor. Journal: GastroHep Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial. Issue 9 (15th June 2022) Authors: Evon, Donna M.; Dong, Meichen; Reeve, Bryce B.; Peter, Joy; Michael, Larry; Lok, Anna S.; Nelson, David R.; Stewart, Paul W. Journal: Journal of viral hepatitis Issue: Volume 29:Issue 9(2022) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗